Papalois, A. E., Barbatis, C., Chrysikos, D., Korontzi, M., Sideris, M., Pittaras, T., . . . Triantafillidis, J. K. (2019). Treatment with Molgramostim (Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor, Rhugm-Csf, Mielogen) and Lenograstim (Granulocyte-Colony Stimulating Factor) Improves Experimental Colitis in Rats. Biomed Res Int.
シカゴスタイル引用形Papalois, Apostolos E., Calypso Barbatis, Dimosthenis Chrysikos, Maria Korontzi, Michail Sideris, Theodoros Pittaras, Eleni Triantafyllidi, Alexandros Nomikos, , John K. Triantafillidis. "Treatment With Molgramostim (Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor, Rhugm-Csf, Mielogen) and Lenograstim (Granulocyte-Colony Stimulating Factor) Improves Experimental Colitis in Rats." Biomed Res Int 2019.
MLA引用形式Papalois, Apostolos E., et al. "Treatment With Molgramostim (Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor, Rhugm-Csf, Mielogen) and Lenograstim (Granulocyte-Colony Stimulating Factor) Improves Experimental Colitis in Rats." Biomed Res Int 2019.